Background Radio-guided surgery (RGS) holds promise for improving surgical outcomes in
neuroendocrine tumors (NETs). Previous studies showed low specificity (SP) using γ-probes …

Background: In neuroendocrine tumor (NET), complete surgery could better the prognosis.
Radioguided surgery (RGS) with β−-radioisotopes is a novel approach focused on …

Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare neoplasms, but the
incidence is rising. Surgery plays a central role in its management, as it is the only …

Purpose Radio-guided surgery (RGS) is an intra-operative localising technique which
enables identification of tissue “marked” by a specific radiotracer injected before surgery. It is …

Background Somatostatin receptor scintigraphy (SRS; octreoscan) is used in
neuroendocrine tumors to locate the primary tumor site and delineate the extent of disease …

Neuroendocrine tumors are rare neoplasms. In most cases conventional imaging
techniques (US, CT, RMN) are not able to identify primitive tumors. This fact conditions the …

The majority of Neuroendocrine tumors (NET) express somatostatin (SS) receptors, and thus
can be successfully targeted with radiolabeled SS analogs in vivo. Somatostatin receptor …

Radioguided surgery (RGS) is a surgical technique that, using intra-operative probes,
enables the surgeon to identify tissues preoperatively “marked” by a radiopharmaceutical …

Neuroendocrine tumours (NETs) may be fatal, though at a significantly slower pace than
their exocrine counterparts. Nuclear medicine procedures for diagnosis and treatment of …

Background: Previous studies of the intraoperative use of a hand-held gamma probe to
localize metastases and primary tumors have shown improved assessment of tumor spread …